Serum seladin-1 levels in diabetes mellitus and Alzheimer's disease patients.

Attila Onmez Merve Alpay Serkan Torun I Ethem Şahin Kürşad Öneç Yıldız Değirmenci

Published in: Acta neurologica Belgica (2020)

Decreased serum seladin-1 values in the presence of DM and inverse correlations with diabetic parameters in patients with AD, together with a non-significant difference from the control group, suggests that seladin-1 may be altered only in the presence of DM in patients with AD. Lower serum seladin-1 levels may also play a role in the pathogenesis of AD in patients with DM.

Keyphrases

end stage renal disease
glycemic control
newly diagnosed
ejection fraction
type diabetes
chronic kidney disease
metabolic syndrome
weight loss
wound healing
mild cognitive impairment